🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Chronic Disease Co-Care Pilot Scheme

RecruitingNAAges 45 Years - anyAllThe University of Hong Kong
NCT06310148 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Chronic Disease Co-Care (CDCC) Pilot Scheme is initiated for early screening and management of people with hypertension (HT), pre-diabetes mellitus (pre-DM) and diabetes mellitus (DM) in Hong Kong. This study will evaluate the quality of care, feasibility, acceptability, effectiveness and cost-effectiveness of the Scheme. This is a 12-month cohort study among the District Health Centre (DHC) or DHC Express, healthcare providers, CDCC participants and a comparison group of 1,886 non-participants. All the person-in charge, 2 family doctors and 1 of each allied health provider from each DHC/DHC Express will be administered with the questionnaires on quality of care and costing. All CDCC participants will be included in subject characteristics, among which a convenience sample of 548 will complete a telephone survey on experience, enablement and satisfaction of the CDCC Pilot Scheme. Th

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria of interventional group: * Hong Kong residents * Aged ≥45 years * Registered as a member of DHC/DHC Express * Provided informed consent on sharing their data in the electronic Health Record Sharing System * Provided consent to join the CDCC Pilot Scheme Terms and Conditions. Exclusion Criteria of interventional group: * With known history of DM or HT Inclusion Criteria of comparison group: * Hong Kong residents * Aged ≥45 years * Provided informed consent for the study. Exclusion Criteria of comparison group: * Without known history of DM or HT
💊

What it tests

  • The Chronic Disease Co-Care (CDCC) Pilot Scheme
📍

Where

1 site
Jockey Club Building for Interdisciplinary Research 5 Sassoon Road, Pok Fu Lam, HONG KONG
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy